Argonaute RNA
Developer of therapeutic medicines designed to harness the body's natural cell mechanisms to combat illness. The company's platform uses a novel method of stabilizing the small interfering ribonucleic...
Valuation
$11.6M
Market implied
Share Price
N/A
Total Raised
$5.5M
Last Round
N/A